Portfolio company
PhoreMost
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops a phenotypic screening platform to identify new drug targets for pharmaceutical and biotechnology partners in oncology and inflammation.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Spark BioPharma
The company develops small-molecule therapeutics using a phenotypic discovery platform for pharmaceutical partners treating cancer, inflammation and immune disorders.
Phenomic AI
This company develops a machine learning platform for drug discovery through cell imaging and single-cell RNA sequencing for pharmaceutical and biotechnology partners.
Pepper Bio
This company develops transomics software to identify biological targets and drug candidates for pharmaceutical and biotechnology researchers.
Kinomica Limited
This company develops a phosphoproteomic diagnostic platform to help clinicians and pharmaceutical firms select targeted cancer therapies for individual patients.
Fore Bio
This biotechnology company develops precision oncology therapies and small-molecule inhibitors for patients with unaddressed tumour mutations and hard-to-treat cancers.
Pharos IBT
This company develops artificial intelligence platforms for discovering and developing treatments for rare and refractory diseases for the pharmaceutical and biotechnology industries.
Orbit Discovery
The company provides a peptide display platform for biotechnology and pharmaceutical partners to identify and optimise lead compounds for novel therapeutic drug development.
Amphista Therapeutics
This company develops targeted protein degradation medicines to treat patients with cancer and other diseases.
